Lawyer Control of the Tobacco Industry's External Research Program

JAMAPublished 19 July 1995

Lisa Bero

DOI10.1001/jama.1995.03530030061035

Source URL

Citations92

SJR quartileQ1

SJR score5.35

SNIP10.71

TL;DR

Abstract

The involvement of tobacco industry lawyers in the selection of scientific projects to be funded is in sharp contrast to the industry's public statements about its review process for its external research program. Scientific merit played little role in the selection of external research projects. The results of the projects were used to generate good publicity for the industry, to deflect attention away from tobacco use as a health danger, and to attempt, sometimes surreptitiously, to influence policymakers.

Keywords

Health ProfessionsPharmacology, Toxicology and Pharmaceutics

New England Journal of MedicineThe Publication of Sponsored Symposiums in Medical Journals

170 Citations1992Lisa Bero, Alison Galbraith +1 more

Symposiums sponsored by drug companies often have promotional attributes and are not peer-reviewed, and financial relations among symposium participants, sponsors, and journals should be completely disclosed, symposiums should be clearly identified, and journal editors should maintain editorial control over contributions.

View PDF

JAMAThe Politics of Local Tobacco Control

129 Citations1991Bruce E. Samuels

Despite the tobacco industry's superior financial resources, the outcome of proposed local tobacco control legislation appears to depend on how seriously the health advocates mobilize in support of the local legislation, and the health community makes a serious commitment of time and resources, it wins.

JAMALooking Through a Keyhole at the Tobacco Industry

123 Citations1995Stanton A. Glantz

These documents provide the first look at the inner workings of the tobacco industry during the crucial period in which the scientific case that smoking is addictive and kills smokers solidified.

New England Journal of MedicineMortality in Middle-Aged Smokers and Nonsmokers

110 Citations1979Gary Friedman, Loring G. Dales +1 more

This analysis did not support the counterhypothesis that the association of cigarette smoking with mortality is secondary to some underlying characteristic, and it was found that the smoker-to-nonsmoker mortality ratios were 2.6 and 2.1 for all causes and 4.6 for coronary heart disease.

JAMAEnvironmental Tobacco Smoke

99 Citations1995Deborah E. Barnes

This study examines the tobacco industry's public and private responses to rising concern over the health effects of environmental tobacco smoke (ETS) and its implications for public health.

JAMANicotine and Addiction

98 Citations1995John Slade

The documents reveal an intention on the part of B&W and its corporate parent to affect the function of the body with nicotine.

JAMASponsored Symposia on Environmental Tobacco Smoke

66 Citations1994Lisa Bero

Symposia on environmental tobacco smoke are more likely to present unbalanced data and be authored by tobacco industry-affiliated individuals than journal articles on ETS and the publication records and affiliations of authors of symposia with the authors of scientific consensus documents are compared.

The Journal of Experimental MedicineActivation of factor XII by tobacco glycoprotein.

58 Citations1977C G Becker, T Dubin

The presence in cigarette smoke of material that is both allergenic and capable of activating factor XII of the intrinsic pathway of coagulatin may be important to the pathogenesis of cardiovascular and pulmonary disease associated with cigarette smoking.

View PDF

RePEc: Research Papers in EconomicsTobacco Industry Response to a Risk Assessment of Environmental Tobacco Smoke

4 Citations1993Lisa Bero, Stanton A. Glantz

View PDF